RECURRENT CUTANEOUS MELANOMA
Clinical trials for RECURRENT CUTANEOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CUTANEOUS MELANOMA trials appear
Sign up with your email to follow new studies for RECURRENT CUTANEOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Melanoma drug combo trial halted after just 3 patients
Disease control TerminatedThis study tested two drugs, encorafenib and binimetinib, given before surgery to people with a certain type of advanced melanoma (stage IIIB-D) that had spread to lymph nodes. The goal was to see if the drugs could shrink or eliminate the cancer before removal. The trial was sto…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Experimental immune cell combo for Kids' cancers halted early
Disease control TerminatedThis early-phase trial aimed to find the safest dose of donor natural killer (NK) cells combined with chemotherapy for children and young adults with solid tumors that returned or didn't respond to treatment. The NK cells were grown from donated cord blood and given alongside sta…
Matched conditions: RECURRENT CUTANEOUS MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:37 UTC